XML 222 R187.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF REGISTRANT (Parent Company Only) - Statement of Cash Flows (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash Flows from Operating Activities                      
Net income $ 377 $ 872 $ 890 $ 417 $ 649 $ 1,061 $ 614 $ 825 $ 2,556 $ 3,149 [1],[2] $ 3,417 [1],[2]
Net cash provided by (used in) operating activities                 4,685 4,407 [2] 3,325 [2]
Available-for-Sale securities:                      
Proceeds from sales                 734 1,306 [2] 556 [2]
Maturities, sinking fund payments and calls                 9,230 7,621 [2] 11,501 [2]
Purchases                 (19,694) (22,034) [2] (14,718) [2]
Purchase of other investments                 (116) (99) [2] (97) [2]
Purchase of land, buildings, equipment and software                 (184) (182) [2] (120) [2]
Other, net                 (180) (31) [2] (10) [2]
Net cash provided by (used in) investing activities                 (9,262) (13,583) [2] (4,380) [2]
Cash Flows from Financing Activities                      
Dividends paid to shareholders                 (550) (534) [2] (511) [2]
Repurchase of common shares                 (2,127) (1,978) [2] (2,030) [2]
Repayments of long-term debt                 (760) (510) [2] (9) [2]
Exercise of stock options                 0 0 [2] 1 [2]
Other, net                 1 2 [2] (14) [2]
Net cash provided by (used in) financing activities                 4,411 8,430 [2] 1,723 [2]
Net increase (decrease) in cash and cash equivalents, including amounts restricted                 (135) (814) [2] 666 [2]
Cash and cash equivalents, including amounts restricted at beginning of period [2]       8,755       9,569 8,755 9,569 8,903
Cash and cash equivalents, including amounts restricted at end of period 8,620       8,755 [2]       8,620 8,755 [2] 9,569 [2]
Supplemental Disclosures:                      
Income taxes paid, net                 1,036 500 [2] 986 [2]
Ameriprise Financial, Inc.                      
Cash Flows from Operating Activities                      
Net income                 2,556 3,149 [3] 3,417 [4]
Equity in earnings of subsidiaries                 (3,141) (3,647) [3] (3,907) [3]
Dividends received from subsidiaries                 3,025 2,512 [4] 4,027 [4]
Other operating activities, primarily with subsidiaries                 453 226 [4] 343 [4]
Net cash provided by (used in) operating activities                 2,893 2,240 [4] 3,880 [4]
Available-for-Sale securities:                      
Proceeds from sales                 4 0 [4] 0 [4]
Maturities, sinking fund payments and calls                 43 153 [4] 93 [4]
Purchases                 (38) (124) [4] (82) [4]
Proceeds from sale of other investments                 0 7 [4] 1 [4]
Purchase of other investments                 (10) (1) [4] (16) [4]
Proceeds from sale of land, buildings, equipment and software                 0 0 [4] 1 [4]
Purchase of land, buildings, equipment and software                 (87) (70) [4] (28) [4]
Contributions to subsidiaries                 (324) (743) [4] (1,291) [4]
Return of capital from subsidiaries                 0 207 [4] 39 [4]
Repayment of loans from subsidiaries                 1,992 1,960 [4] 2,701 [4]
Issuance of loans to subsidiaries                 (2,232) (1,726) [4] (2,937) [4]
Other, net                 2 0 [4] 0 [4]
Net cash provided by (used in) investing activities                 (650) (337) [4] (1,519) [4]
Cash Flows from Financing Activities                      
Dividends paid to shareholders                 (550) (534) [4] (511) [4]
Repurchase of common shares                 (2,127) (1,978) [4] (2,030) [4]
Issuance of long-term debt, net of issuance costs                 1,335 495 [4] 4 [4]
Repayments of long-term debt                 (760) (510) [4] (9) [4]
Borrowings from subsidiaries                 1,003 1,210 [4] 244 [4]
Repayments of borrowings from subsidiaries                 (951) (1,034) [4] (403) [4]
Exercise of stock options                 0 0 [4] 1 [4]
Other, net                 (35) (18) [4] 99 [4]
Net cash provided by (used in) financing activities                 (2,085) (2,369) [4] (2,605) [4]
Net increase (decrease) in cash and cash equivalents, including amounts restricted                 158 (466) [4] (244) [4]
Cash and cash equivalents, including amounts restricted at beginning of period [4]       $ 361       $ 827 361 827 1,071
Cash and cash equivalents, including amounts restricted at end of period $ 519       $ 361 [4]       519 361 [4] 827 [4]
Supplemental Disclosures:                      
Interest paid on debt                 129 98 [4] 95 [4]
Income taxes paid, net                 233 91 [4] 173 [4]
Non-cash dividends from subsidiaries                 77 0 [4] 0 [4]
Non-cash contributions to subsidiaries                 $ 0 $ 0 [4] $ 52 [4]
[1] Certain prior period amounts have been restated. See Note 3 for more information.
[2] Certain prior period amounts have been restated. See Note 3 for more information.
[3] Certain prior period amounts have been restated. See Note 1 for more information.
[4] Certain prior period amounts have been restated. See Note 1 for more information.